Effects of graded suppression of the EEG with propofol on the neurological outcome following incomplete cerebral ischaemia in rats.
We evaluated the relation between dose and response for the neuroprotective effect of propofol in a rat model with incomplete cerebral ischaemia. For clarification of the mechanism of neuroprotection, plasma catecholamines and tumour necrosis factor-alpha levels were measured. Three doses (low, moderate and high-dose) of propofol were tested. These produced, respectively, a low amplitude, slowing and a burst-suppression pattern of electroencephalographic activity. Incomplete cerebral ischaemia was produced by right carotid artery occlusion combined with haemorrhagic hypotension (35 mmHg) for 30 min. Neurological outcome at 72 h post-ischaemia in the high-dose group was significantly better than that in both low-dose and moderate-dose groups. Propofol exhibited a trend in the dose-related attenuation of the increases in plasma adrenaline and noradrenaline during ischaemia. Tumour necrosis factor-alpha increased during and after ischaemia in all groups with no intergroup differences. The results indicate that a burst-suppression dose of propofol provides neuroprotection. The protective effect can not be completely explained by the attenuating effect on circulating catecholamines.
Yamasaki
T
T
Department of Anesthesiology-Resuscitology, Yamaguchi University School of Medicine, Japan.
Nakakimura
K
K
Matsumoto
M
M
Xiong
L
L
Ishikawa
T
T
Sakabe
T
T
D018686:Anesthetics, Intravenous / Q000008:administration & dosage*; D000818:Animals; D002545:Brain Ischemia / Q000097:blood / Q000503:physiopathology*; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography / Q000187:drug effects*; D004837:Epinephrine / Q000097:blood; D008297:Male; D009043:Motor Activity; D009638:Norepinephrine / Q000097:blood; D010147:Pain Measurement; D015742:Propofol / Q000008:administration & dosage*; D051381:Rats; D017208:Rats, Wistar; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D018686:Anesthetics, Intravenous; D014409:Tumor Necrosis Factor-alpha; D009638:Norepinephrine; D015742:Propofol; D004837:Epinephrine